Concepts (330)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Life Expectancy | 18 | 2022 | 1248 | 5.590 |
Why?
|
Quality-Adjusted Life Years | 25 | 2022 | 1741 | 3.120 |
Why?
|
Social Isolation | 7 | 2021 | 366 | 2.290 |
Why?
|
Mortality | 11 | 2022 | 2911 | 2.240 |
Why?
|
Disabled Persons | 12 | 2021 | 1210 | 2.160 |
Why?
|
Cause of Death | 13 | 2021 | 3721 | 1.960 |
Why?
|
Child Mortality | 4 | 2021 | 204 | 1.930 |
Why?
|
Socioeconomic Factors | 24 | 2021 | 7852 | 1.450 |
Why?
|
Birth Rate | 3 | 2020 | 168 | 1.380 |
Why?
|
Nitric Oxide | 7 | 2020 | 2149 | 1.290 |
Why?
|
Diarrhea | 3 | 2020 | 1320 | 1.270 |
Why?
|
Wounds and Injuries | 6 | 2022 | 2517 | 1.260 |
Why?
|
Age Distribution | 12 | 2021 | 2873 | 1.200 |
Why?
|
Stress, Psychological | 7 | 2021 | 4530 | 1.170 |
Why?
|
Developing Countries | 7 | 2021 | 2910 | 1.150 |
Why?
|
Occupational Exposure | 4 | 2020 | 1807 | 1.120 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 4 | 2018 | 903 | 1.120 |
Why?
|
Hindlimb Suspension | 3 | 2019 | 76 | 1.030 |
Why?
|
Infant Mortality | 2 | 2021 | 752 | 1.000 |
Why?
|
Onchocerciasis | 2 | 2022 | 28 | 0.990 |
Why?
|
Respiratory Tract Infections | 3 | 2022 | 1014 | 0.940 |
Why?
|
Sex Distribution | 9 | 2021 | 2278 | 0.920 |
Why?
|
Prevalence | 20 | 2022 | 15869 | 0.920 |
Why?
|
Swimming | 6 | 2019 | 209 | 0.890 |
Why?
|
Receptors, Opioid, delta | 2 | 2020 | 48 | 0.800 |
Why?
|
Hippocampus | 8 | 2020 | 3783 | 0.790 |
Why?
|
Morbidity | 4 | 2022 | 1755 | 0.790 |
Why?
|
Risk Factors | 28 | 2022 | 74944 | 0.770 |
Why?
|
Spinal Cord Injuries | 5 | 2021 | 928 | 0.770 |
Why?
|
Antidepressive Agents | 5 | 2019 | 2913 | 0.760 |
Why?
|
Seizures | 6 | 2020 | 2998 | 0.760 |
Why?
|
Depression | 7 | 2018 | 8230 | 0.750 |
Why?
|
Incidence | 20 | 2022 | 21538 | 0.740 |
Why?
|
Minocycline | 2 | 2019 | 170 | 0.730 |
Why?
|
Bayes Theorem | 7 | 2022 | 2359 | 0.710 |
Why?
|
Child, Preschool | 20 | 2022 | 42669 | 0.680 |
Why?
|
Antipruritics | 1 | 2019 | 31 | 0.670 |
Why?
|
Disability Evaluation | 3 | 2022 | 1835 | 0.660 |
Why?
|
Wasting Syndrome | 1 | 2020 | 96 | 0.660 |
Why?
|
Locomotion | 5 | 2020 | 388 | 0.640 |
Why?
|
Urologic Neoplasms | 1 | 2023 | 314 | 0.640 |
Why?
|
Poverty | 2 | 2021 | 2720 | 0.630 |
Why?
|
Measles | 1 | 2020 | 180 | 0.620 |
Why?
|
Anxiety | 4 | 2018 | 4672 | 0.610 |
Why?
|
Nutritional Status | 3 | 2021 | 1628 | 0.610 |
Why?
|
Population Density | 1 | 2018 | 193 | 0.600 |
Why?
|
Chloroquine | 1 | 2019 | 276 | 0.590 |
Why?
|
Male | 61 | 2022 | 364731 | 0.590 |
Why?
|
Toll-Like Receptor 4 | 1 | 2021 | 588 | 0.590 |
Why?
|
Developed Countries | 1 | 2020 | 451 | 0.580 |
Why?
|
Receptors, Opioid, kappa | 1 | 2018 | 136 | 0.570 |
Why?
|
Receptors, Opioid, mu | 1 | 2018 | 171 | 0.570 |
Why?
|
Neoplasms | 8 | 2022 | 22371 | 0.560 |
Why?
|
Infant | 16 | 2021 | 36535 | 0.560 |
Why?
|
Mitochondria | 3 | 2019 | 3683 | 0.560 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2017 | 48 | 0.560 |
Why?
|
Meningitis | 1 | 2018 | 219 | 0.550 |
Why?
|
Education | 1 | 2019 | 533 | 0.550 |
Why?
|
Amphetamine | 1 | 2018 | 222 | 0.540 |
Why?
|
Anticonvulsants | 4 | 2020 | 1923 | 0.540 |
Why?
|
Models, Statistical | 3 | 2020 | 5107 | 0.540 |
Why?
|
Aged, 80 and over | 19 | 2022 | 59626 | 0.530 |
Why?
|
Fluid Therapy | 1 | 2020 | 587 | 0.530 |
Why?
|
Healthcare Disparities | 3 | 2020 | 3415 | 0.520 |
Why?
|
Infant, Newborn | 13 | 2021 | 26421 | 0.520 |
Why?
|
Potassium Channels | 1 | 2019 | 538 | 0.520 |
Why?
|
Pruritus | 1 | 2019 | 379 | 0.510 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2017 | 137 | 0.510 |
Why?
|
Risk Assessment | 8 | 2022 | 24318 | 0.510 |
Why?
|
Serotonin Antagonists | 1 | 2016 | 147 | 0.500 |
Why?
|
Behavior, Animal | 7 | 2019 | 1862 | 0.500 |
Why?
|
Receptors, Opioid | 1 | 2016 | 145 | 0.500 |
Why?
|
Ondansetron | 1 | 2016 | 95 | 0.490 |
Why?
|
Cyclic GMP | 1 | 2016 | 394 | 0.470 |
Why?
|
Cost of Illness | 2 | 2022 | 1951 | 0.470 |
Why?
|
Metformin | 2 | 2019 | 909 | 0.470 |
Why?
|
Geography | 3 | 2022 | 652 | 0.460 |
Why?
|
Young Adult | 19 | 2021 | 60066 | 0.460 |
Why?
|
Hepatitis B | 1 | 2020 | 711 | 0.460 |
Why?
|
Adolescent | 21 | 2022 | 89169 | 0.450 |
Why?
|
Female | 42 | 2022 | 397187 | 0.440 |
Why?
|
Encephalitis | 1 | 2017 | 441 | 0.440 |
Why?
|
Humans | 64 | 2023 | 768171 | 0.430 |
Why?
|
Goals | 1 | 2018 | 717 | 0.430 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1250 | 0.420 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2018 | 628 | 0.420 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2016 | 491 | 0.410 |
Why?
|
Gout | 1 | 2020 | 621 | 0.410 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2004 | 0.410 |
Why?
|
Colorectal Neoplasms | 3 | 2022 | 6975 | 0.400 |
Why?
|
Child | 17 | 2022 | 80917 | 0.400 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4045 | 0.400 |
Why?
|
Fractures, Bone | 2 | 2021 | 2062 | 0.390 |
Why?
|
Health Status | 3 | 2019 | 4091 | 0.390 |
Why?
|
Aged | 25 | 2022 | 171502 | 0.390 |
Why?
|
Metabolic Diseases | 1 | 2018 | 684 | 0.390 |
Why?
|
Fluoxetine | 1 | 2016 | 733 | 0.390 |
Why?
|
Overweight | 2 | 2020 | 2448 | 0.390 |
Why?
|
Anemia | 1 | 2021 | 1514 | 0.390 |
Why?
|
Sulfonamides | 1 | 2021 | 1982 | 0.380 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.380 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2222 | 0.380 |
Why?
|
Adult | 26 | 2022 | 223646 | 0.370 |
Why?
|
Indoles | 2 | 2017 | 1836 | 0.370 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1518 | 0.360 |
Why?
|
Nicotine | 1 | 2015 | 680 | 0.350 |
Why?
|
Communicable Diseases | 1 | 2018 | 873 | 0.350 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1668 | 0.330 |
Why?
|
Hepatitis C | 1 | 2020 | 1595 | 0.330 |
Why?
|
Africa | 3 | 2021 | 725 | 0.330 |
Why?
|
Occupational Diseases | 4 | 2020 | 1457 | 0.330 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1960 | 0.320 |
Why?
|
Central Nervous System Stimulants | 1 | 2018 | 1168 | 0.320 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1481 | 0.320 |
Why?
|
Middle Aged | 22 | 2022 | 223487 | 0.310 |
Why?
|
Nitrites | 3 | 2018 | 156 | 0.310 |
Why?
|
Mice | 18 | 2021 | 82049 | 0.310 |
Why?
|
United Nations | 2 | 2019 | 151 | 0.310 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1662 | 0.300 |
Why?
|
Vaccination | 1 | 2020 | 3437 | 0.300 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2019 | 2442 | 0.290 |
Why?
|
Influenza, Human | 1 | 2018 | 1541 | 0.280 |
Why?
|
Environmental Exposure | 2 | 2020 | 4543 | 0.280 |
Why?
|
Dizocilpine Maleate | 2 | 2018 | 171 | 0.270 |
Why?
|
Respiration Disorders | 1 | 2020 | 364 | 0.270 |
Why?
|
Registries | 2 | 2020 | 8375 | 0.270 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10763 | 0.260 |
Why?
|
Animals | 25 | 2021 | 169285 | 0.260 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2298 | 0.250 |
Why?
|
Skin | 1 | 2019 | 4505 | 0.250 |
Why?
|
Ivermectin | 2 | 2022 | 48 | 0.250 |
Why?
|
Atherosclerosis | 1 | 2021 | 3433 | 0.250 |
Why?
|
Demography | 2 | 2020 | 1641 | 0.250 |
Why?
|
Crohn Disease | 1 | 2017 | 2295 | 0.240 |
Why?
|
Narcotic Antagonists | 2 | 2020 | 591 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4058 | 0.230 |
Why?
|
Internationality | 2 | 2020 | 1008 | 0.230 |
Why?
|
Malnutrition | 2 | 2020 | 632 | 0.220 |
Why?
|
Epilepsy | 1 | 2019 | 3326 | 0.210 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18349 | 0.210 |
Why?
|
Yemen | 1 | 2022 | 10 | 0.210 |
Why?
|
Pyridinolcarbamate | 1 | 2022 | 4 | 0.210 |
Why?
|
Neuralgia | 2 | 2020 | 622 | 0.200 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6395 | 0.200 |
Why?
|
Ghana | 1 | 2022 | 333 | 0.190 |
Why?
|
Life Tables | 1 | 2021 | 367 | 0.190 |
Why?
|
Pituitary-Adrenal System | 2 | 2021 | 555 | 0.180 |
Why?
|
Basement Membrane | 1 | 2021 | 348 | 0.180 |
Why?
|
Maternal Deprivation | 2 | 2018 | 40 | 0.180 |
Why?
|
Sumatriptan | 1 | 2020 | 66 | 0.180 |
Why?
|
Australasia | 1 | 2020 | 21 | 0.180 |
Why?
|
Oceania | 1 | 2020 | 21 | 0.170 |
Why?
|
Asia, Central | 1 | 2020 | 13 | 0.170 |
Why?
|
Azithromycin | 1 | 2021 | 201 | 0.170 |
Why?
|
Europe, Eastern | 1 | 2020 | 72 | 0.170 |
Why?
|
Age Factors | 4 | 2019 | 18415 | 0.170 |
Why?
|
Egypt | 1 | 2020 | 100 | 0.170 |
Why?
|
Trophoblasts | 1 | 2021 | 223 | 0.170 |
Why?
|
Enzyme Inhibitors | 3 | 2019 | 3728 | 0.170 |
Why?
|
Receptors, Glucocorticoid | 1 | 2021 | 309 | 0.160 |
Why?
|
Censuses | 1 | 2020 | 198 | 0.160 |
Why?
|
Nigeria | 1 | 2022 | 781 | 0.160 |
Why?
|
Sanitation | 1 | 2019 | 83 | 0.160 |
Why?
|
Health Surveys | 2 | 2020 | 4057 | 0.160 |
Why?
|
Rural Health | 1 | 2020 | 302 | 0.160 |
Why?
|
Singapore | 1 | 2020 | 300 | 0.160 |
Why?
|
Signal Transduction | 3 | 2020 | 23648 | 0.160 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2019 | 262 | 0.160 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2360 | 0.160 |
Why?
|
KATP Channels | 1 | 2019 | 49 | 0.160 |
Why?
|
Population Growth | 1 | 2018 | 50 | 0.160 |
Why?
|
Hospitalization | 1 | 2018 | 10840 | 0.160 |
Why?
|
Latin America | 1 | 2020 | 416 | 0.150 |
Why?
|
Macrophage Activation | 1 | 2021 | 557 | 0.150 |
Why?
|
Wrist | 1 | 2020 | 231 | 0.150 |
Why?
|
Child Nutrition Disorders | 1 | 2020 | 140 | 0.150 |
Why?
|
Asia | 1 | 2020 | 630 | 0.150 |
Why?
|
Asbestos | 1 | 2020 | 251 | 0.150 |
Why?
|
Urban Health | 1 | 2020 | 535 | 0.150 |
Why?
|
Sex Factors | 3 | 2019 | 10632 | 0.150 |
Why?
|
Chemokines | 1 | 2022 | 963 | 0.150 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 404 | 0.150 |
Why?
|
Corticosterone | 1 | 2018 | 301 | 0.150 |
Why?
|
Central Nervous System Agents | 1 | 2018 | 73 | 0.150 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2020 | 162 | 0.150 |
Why?
|
Naltrexone | 1 | 2020 | 319 | 0.150 |
Why?
|
Carcinogens | 1 | 2020 | 453 | 0.150 |
Why?
|
Suicide | 1 | 2019 | 1606 | 0.140 |
Why?
|
Organizational Objectives | 1 | 2019 | 426 | 0.140 |
Why?
|
Wrist Injuries | 1 | 2020 | 215 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 702 | 0.140 |
Why?
|
Hand Injuries | 1 | 2020 | 239 | 0.140 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 752 | 0.140 |
Why?
|
Benzenesulfonates | 1 | 2017 | 170 | 0.140 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1606 | 0.140 |
Why?
|
Live Birth | 1 | 2020 | 516 | 0.140 |
Why?
|
Stroke | 1 | 2019 | 9755 | 0.140 |
Why?
|
Exploratory Behavior | 1 | 2018 | 272 | 0.140 |
Why?
|
Injections | 1 | 2019 | 841 | 0.130 |
Why?
|
North America | 1 | 2020 | 1289 | 0.130 |
Why?
|
Inflammation | 5 | 2020 | 10873 | 0.130 |
Why?
|
Europe | 2 | 2020 | 3436 | 0.130 |
Why?
|
Naphthalenes | 1 | 2017 | 198 | 0.130 |
Why?
|
Lithium Chloride | 1 | 2016 | 83 | 0.130 |
Why?
|
Molecular Imaging | 1 | 2023 | 826 | 0.130 |
Why?
|
Flavonoids | 1 | 2019 | 447 | 0.130 |
Why?
|
Uncertainty | 1 | 2020 | 769 | 0.130 |
Why?
|
Maternal Age | 1 | 2018 | 805 | 0.130 |
Why?
|
Dermatologic Agents | 1 | 2019 | 313 | 0.120 |
Why?
|
Benzoxazines | 1 | 2017 | 320 | 0.120 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.120 |
Why?
|
Neuroprotective Agents | 2 | 2020 | 958 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21207 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1194 | 0.120 |
Why?
|
Random Allocation | 1 | 2019 | 2395 | 0.120 |
Why?
|
Sex Offenses | 1 | 2018 | 357 | 0.120 |
Why?
|
Immobilization | 1 | 2015 | 229 | 0.120 |
Why?
|
Pentylenetetrazole | 3 | 2020 | 72 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 582 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1667 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15662 | 0.110 |
Why?
|
Forecasting | 2 | 2021 | 2945 | 0.110 |
Why?
|
Morpholines | 1 | 2017 | 584 | 0.110 |
Why?
|
Mesothelioma | 1 | 2020 | 811 | 0.110 |
Why?
|
World Health Organization | 1 | 2020 | 1328 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1854 | 0.110 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 809 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2018 | 969 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1573 | 0.110 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 344 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2211 | 0.110 |
Why?
|
Health Care Surveys | 1 | 2020 | 2434 | 0.110 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2015 | 451 | 0.100 |
Why?
|
Oxytocin | 1 | 2017 | 404 | 0.100 |
Why?
|
Testicular Neoplasms | 1 | 2019 | 806 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2020 | 973 | 0.100 |
Why?
|
HIV Infections | 1 | 2019 | 17569 | 0.100 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 836 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4149 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1725 | 0.100 |
Why?
|
Air Pollution, Indoor | 1 | 2020 | 931 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1512 | 0.100 |
Why?
|
Spinal Cord | 4 | 2021 | 1812 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2022 | 2649 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1388 | 0.100 |
Why?
|
Low Back Pain | 1 | 2020 | 990 | 0.090 |
Why?
|
History, 20th Century | 1 | 2019 | 2766 | 0.090 |
Why?
|
Income | 1 | 2020 | 1878 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1408 | 0.090 |
Why?
|
Social Class | 1 | 2020 | 2008 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1810 | 0.090 |
Why?
|
Pneumoconiosis | 1 | 2020 | 32 | 0.090 |
Why?
|
Particulate Matter | 1 | 2022 | 2617 | 0.090 |
Why?
|
Iran | 1 | 2022 | 763 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2018 | 6229 | 0.080 |
Why?
|
Body Mass Index | 2 | 2022 | 13053 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3948 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4627 | 0.080 |
Why?
|
Colitis | 1 | 2017 | 1242 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1667 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2021 | 10478 | 0.070 |
Why?
|
Nitric Oxide Synthase Type I | 2 | 2020 | 175 | 0.070 |
Why?
|
Motivation | 1 | 2018 | 2020 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3239 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5536 | 0.070 |
Why?
|
Pyrazoles | 1 | 2017 | 2028 | 0.070 |
Why?
|
Public Health | 1 | 2019 | 2679 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2021 | 19025 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3007 | 0.060 |
Why?
|
Cross-Cultural Comparison | 1 | 2019 | 638 | 0.060 |
Why?
|
Smoking | 1 | 2022 | 9092 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12840 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6498 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2740 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 4423 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 40220 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 3729 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3837 | 0.050 |
Why?
|
Diet | 1 | 2020 | 8089 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7477 | 0.050 |
Why?
|
Rats | 3 | 2021 | 23782 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2019 | 81760 | 0.040 |
Why?
|
Amnion | 1 | 2021 | 204 | 0.040 |
Why?
|
Hypertension | 1 | 2020 | 8616 | 0.040 |
Why?
|
Cromakalim | 1 | 2019 | 23 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2019 | 2709 | 0.040 |
Why?
|
Glyburide | 1 | 2019 | 117 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2020 | 8142 | 0.040 |
Why?
|
State Medicine | 1 | 2020 | 219 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13490 | 0.040 |
Why?
|
Regenerative Medicine | 1 | 2021 | 313 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2021 | 1890 | 0.040 |
Why?
|
Vasotocin | 1 | 2017 | 10 | 0.040 |
Why?
|
Cadherins | 1 | 2021 | 905 | 0.030 |
Why?
|
Hormone Antagonists | 1 | 2017 | 108 | 0.030 |
Why?
|
Microcirculation | 1 | 2021 | 1281 | 0.030 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 187 | 0.030 |
Why?
|
Convulsants | 1 | 2016 | 70 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2018 | 1769 | 0.030 |
Why?
|
Nitric Oxide Donors | 1 | 2016 | 126 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 41753 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1250 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13586 | 0.030 |
Why?
|
Environment | 1 | 2021 | 1121 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 2018 | 911 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3252 | 0.030 |
Why?
|
Chronic Disease | 1 | 2020 | 9384 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2021 | 951 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
Arginine | 1 | 2018 | 932 | 0.030 |
Why?
|
Hyperalgesia | 1 | 2018 | 527 | 0.030 |
Why?
|
Fruit | 1 | 2019 | 1165 | 0.030 |
Why?
|
Vegetables | 1 | 2019 | 1199 | 0.030 |
Why?
|
Analgesics | 1 | 2020 | 1071 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3628 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2683 | 0.030 |
Why?
|
Microglia | 1 | 2021 | 1376 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2019 | 65379 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2021 | 1893 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2631 | 0.020 |
Why?
|
Antioxidants | 1 | 2019 | 1676 | 0.020 |
Why?
|
Antigens, CD | 1 | 2021 | 4035 | 0.020 |
Why?
|
Asthma | 1 | 2020 | 6291 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3517 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2981 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11095 | 0.020 |
Why?
|
Apoptosis | 1 | 2019 | 9527 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 30255 | 0.010 |
Why?
|
Concepts
(330)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_